Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Blockade of endogenous interleukin 12 results in suppression of murine streptococcal cell wall arthritis by enhancement of interleukin 10 and interleukin 1Ra

Article Abstract:

Blocking the activity of interleukin-12 may benefit arthritis patients. In a study of mice with experimentally induced arthritis, a chemical that blocks IL-12 reduced joint swelling. This shows that interleukin-12 stimulates inflammation.

Author: Joosten, Leo A.B., Helsen, Monique M.A., Berg, Wim B. van den
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2000
Research, Inflammation, Inflammation mediators, Interleukin-12

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Chondrite IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis

Article Abstract:

Arthritis may impair the functioning of insulin like growth factor-1 (IGF-1) receptors. IGF-1 normally regulates protein production in healthy joint cartilage cells. Researchers measured the IGF-1 receptor expression in healthy mouse cartilage and the response to IGF-1 stimulation in arthritis-induced mouse cartilage. They found the majority of the IGF-1 receptors in the middle and deeper layers of the healthy mouse cartilage. Cartilage cells lost their capacity to respond to IGF-1, protein production decreased by 80%, and joint swelling was observed twelve hours after enzyme-induced arthritis. Four days later IGF-1 response, protein production, and joint inflammation returned to normal levels. They saw a similar response cycle with antigen-induced arthritis. However, IGF-1 response returned in 24 hours and protein production recovered in seven days with antigen-induced arthritis.

Author: Joosten, Leo A.B., Berg, Wim B. van den, Verschure, Pernette J., Marle, Jan van
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1995
Rheumatoid arthritis, Insulin-like growth factors, Somatomedins, Articular cartilage

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction

Article Abstract:

Drugs to treat arthritis would need to block the activity of both tumor necrosis factor and interleukin-1. These are proteins produced by the body that are involved in inflammatory processes. Both have been implicated in the development of arthritis.

Author: Joosten, Leo A.B., Berg, Wim B. van den, Kollias, George, Loo, Fons A.J. van de
Publisher: British Medical Association
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1999
Tumor necrosis factor, Interleukin-1

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, Arthritis
Similar abstracts:
  • Abstracts: A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. New treatment options for tremors
  • Abstracts: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis
  • Abstracts: Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction?
  • Abstracts: Corticotropin-releasing hormone: a biochemical predictor of preterm delivery in a pilot randomized trial of the treatment of preterm labor
  • Abstracts: Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2023 Advameg, Inc.